Abstract

Background. The aim of the study was to evaluate the approaches of pediatric rheumatologists and pediatric hematologists to patients with similar musculoskeletal (MSK) complaints and to highlight the differences that general pediatricians should consider when referring patients to these specialties.

Methods. This is a cross-sectional study involving the patients who applied to pediatric rheumatology centers with MSK complaints and were diagnosed with malignancy, as well as patients who were followed up in pediatric hematology centers with a malignancy diagnosis, and had MSK complaints at the time of admission.

Results. A total of 142 patients were enrolled in the study. Of these patients, 83 (58.4%) applied to pediatric rheumatology centers, and 59 (41.6%) applied to pediatric hematology centers. Acute lymphoblastic leukemia (ALL) was the most common diagnosis among the patients who applied to both centers, with 80 cases (56.3%). The median age of diagnosis was 87 (interquartile range, IQR: 48-140) months. The most common preliminary diagnosis in pediatric rheumatology centers was juvenile idiopathic arthritis (JIA), with 37 cases (44.5%). MSK involvement was mainly seen as arthralgia, and bone pain. While arthralgia (92.7%) was the most common complaint in rheumatology centers, bone pain (88.1%) was more common in hematology centers. The most frequently involved joints were the knee (62.9%), ankle (25.9%), hip (25%), and wrist (14%). The most common laboratory abnormalities were high lactate dehydrogenase (LDH), high C-reactive protein (CRP), anemia, and high erythrocyte sedimentation rate (ESR). Thrombocytopenia, neutropenia, and high LDH were statistically significantly more frequent in patients admitted to hematology centers than in patients admitted to rheumatology centers (p<0.001, p=0.014, p=0.028, respectively). Patients who applied to rheumatology clinics were found to have statistically significantly higher CRP levels (p=0.032).

Conclusions. Malignancies may present with only MSK system complaints in childhood. Therefore, malignancies should be included in the differential diagnosis of patients presenting with MSK complaints.

Keywords: musculoskeletal complaints, malignancy, pediatric rheumatology, pediatric hematology

Supplementary materials
Supplementary Tables

How to cite

1.
Çağlayan Ş, Koç BŞ, Baba Ö, et al. Evaluation of childhood malignancies presenting with musculoskeletal manifestations from two different divisions: a multicenter study. Turk J Pediatr 2024; 66: 81-89. https://doi.org/10.24953/turkjped.2023.446

References

  1. Fuglkjær S, Hartvigsen J, Wedderkopp N, et al. Musculoskeletal extremity pain in Danish school children - how often and for how long? The CHAMPS study-DK. BMC Musculoskelet Disord 2017; 18: 492. https://doi.org/10.1186/s12891-017-1859-8
  2. Clarke RT, Van den Bruel A, Bankhead C, Mitchell CD, Phillips B, Thompson MJ. Clinical presentation of childhood leukaemia: a systematic review and meta-analysis. Arch Dis Child 2016; 101: 894-901. https://doi.org/10.1136/archdischild-2016-311251
  3. Brix N, Hasle H, Rosthøj S, Herlin T. Characteristics of children with acute lymphoblastic leukemia presenting with arthropathy. Clin Rheumatol 2018; 37: 2455-2463. https://doi.org/10.1007/s10067-018-4034-1
  4. Ward ZJ, Yeh JM, Bhakta N, Frazier AL, Girardi F, Atun R. Global childhood cancer survival estimates and priority-setting: a simulation-based analysis. Lancet Oncol 2019; 20: 972-983. https://doi.org/10.1016/S1470-2045(19)30273-6
  5. Fonseca MB, Gomes FHR, Valera ET, et al. Signs and symptoms of rheumatic diseases as first manifestation of pediatric cancer: diagnosis and prognosis implications. Rev Bras Reumatol Engl Ed 2017; 57: 330-337. https://doi.org/10.1016/j.rbre.2017.01.007
  6. Gonçalves M, Terreri MT, Barbosa CM, Len CA, Lee L, Hilário MO. Diagnosis of malignancies in children with musculoskeletal complaints. Sao Paulo Med J 2005; 123: 21-23. https://doi.org/10.1590/s1516-31802005000100005
  7. Balan S, Janarthanan M. Arthritic presentation of malignancies in children: a retrospective study from two centers in South India. Sudan J Paediatr 2022; 22: 47-53. https://doi.org/10.24911/SJP.106-1626506748
  8. Bornstein G, Furie N, Perel N, Ben-Zvi I, Grossman C. Hematological malignancies mimicking rheumatic syndromes: case series and review of the literature. Rheumatol Int 2018; 38: 1743-1749. https://doi.org/10.1007/s00296-018-4107-0
  9. Padhan P, Thakur B, Singh P, Mohanty I, Sahoo SR. Rheumatic manifestations as initial presentation of malignancy: a case series from a tertiary care center in India. Eur J Rheumatol 2018; 6: 71-75. https://doi.org/10.5152/eurjrheum.2018.18140
  10. Cabral DA, Tucker LB. Malignancies in children who initially present with rheumatic complaints. J Pediatr 1999; 134: 53-57. https://doi.org/10.1016/s0022-3476(99)70372-0
  11. Steliarova-Foucher E, Colombet M, Ries LAG, et al. International incidence of childhood cancer, 2001-10: a population-based registry study. Lancet Oncol 2017; 18: 719-731. https://doi.org/10.1016/S1470-2045(17)30186-9
  12. Brix N, Rosthøj S, Glerup M, Hasle H, Herlin T. Identifying acute lymphoblastic leukemia mimicking juvenile idiopathic arthritis in children. PLoS One 2020; 15: e0237530. https://doi.org/10.1371/journal.pone.0237530
  13. Robazzi TC, Barreto JH, Silva LR, Santiago MB, Mendonça N. Osteoarticular manifestations as initial presentation of acute leukemias in children and adolescents in Bahia, Brazil. J Pediatr Hematol Oncol 2007; 29: 622-626. https://doi.org/10.1097/MPH.0b013e3181468c55
  14. Kittivisuit S, Sripornsawan P, Songthawee N, Chavananon S, McNeil EB, Chotsampancharoen T. Musculoskeletal involvement in childhood leukemia: characteristics and survival outcomes. Pediatr Rheumatol Online J 2022; 20: 34. https://doi.org/10.1186/s12969-022-00692-9
  15. Kang S, Im HJ, Bae K, Park SS. Influence of musculoskeletal manifestations as the only presenting symptom in B-cell acute lymphoblastic leukemia. J Pediatr 2017; 182: 290-295. https://doi.org/10.1016/j.jpeds.2016.11.072
  16. Raj B K A, Singh KA, Shah H. Orthopedic manifestation as the presenting symptom of acute lymphoblastic leukemia. J Orthop 2020; 22: 326-330. https://doi.org/10.1016/j.jor.2020.05.022
  17. Zombori L, Kovacs G, Csoka M, Derfalvi B. Rheumatic symptoms in childhood leukaemia and lymphoma-a ten-year retrospective study. Pediatr Rheumatol Online J 2013; 11: 20. https://doi.org/10.1186/1546-0096-11-20
  18. Civino A, Alighieri G, Prete E, et al. Musculoskeletal manifestations of childhood cancer and differential diagnosis with juvenile idiopathic arthritis (ONCOREUM): a multicentre, cross-sectional study. Lancet Rheumatol 2021; 3: e507-e516. https://doi.org/10.1016/S2665-9913(21)00086-2
  19. Tamashiro MS, Aikawa NE, Campos LM, Cristofani LM, Odone-Filho V, Silva CA. Discrimination of acute lymphoblastic leukemia from systemic-onset juvenile idiopathic arthritis at disease onset. Clinics (Sao Paulo) 2011; 66: 1665-1669.